Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02032693 · ClinicalTrials.gov registry record · NA
Everycell's Effect on DNA Damage, Inflammation, and Stress
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02032693 is a NA study that has completed, run by University of Miami. The registered enrollment target is 30 participants.
The verdict
NCT02032693, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The investigators are conducting this research because they want to determine if a dietary supplement, called Everycell™, has an effect on the functioning of the study participants' cells. The results of this research will be used to help develop additional strategies for trying to fight the effects of aging. The primary purpose of this study is to determine the effectiveness of Everycell™ compared to placebo (a pill that does nothing) on DNA damage, inflammation, stress, and related factors. Taking Everycell™ is not a medical prescription, treatment, or cure for any known disease or condition. Helping patients' nutritional status is important to prevent the continued worsening of chronic diseases and also to counteract the effects of aging. Americans also have difficulties with compliance to prescription medications due to their toxicity and side effects. This study aims to learn more about how a dietary supplement may improve nutritional status and enable the body to normalize cellular functioning, which may improve quality of life. The results of this research will be used to determine if Everycell™ is beneficial for overall cellular health and to counteract the effects of aging.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Everycell™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02032693
The ClinicalTrials.gov registry entry for NCT02032693 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02032693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02032693 about?
NCT02032693 is a clinical study titled "Everycell's Effect on DNA Damage, Inflammation, and Stress". The investigators are conducting this research because they want to determine if a dietary supplement, called Everycell™, has an effect on the functioning of the study participants' cells. The results of this research will be used to help develop additional strategies for trying to fight the effects...
What is the current status of trial NCT02032693?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2013-12. Estimated completion is 2014-04.
What interventions are being tested in trial NCT02032693?
The interventions under investigation include: Placebo (OTHER), Everycell™ (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02032693?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.